Hironori Betsunoh
Papers
1
Total Citations
12
H-Index
1
About
Dr. Hironori Betsunoh is a distinguished urologic oncologist whose research focuses on improving risk stratification and surgical outcomes for prostate cancer patients. His work centers on refining predictive models using clinical and pathological parameters, particularly in intermediate to high-risk disease. Dr. Betsunoh’s most cited study, "Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy" (2017, 12 citations), demonstrates his commitment to leveraging readily available biopsy data—such as PSA density and core involvement—to guide surgical decision-making, including the need for extended resection or lymph node dissection. This work has helped urologic surgeons better personalize treatment for complex cases. Beyond this, his broader contributions include advancing the understanding of robot-assisted radical prostatectomy outcomes, with a focus on balancing oncological control and functional preservation. Dr. Betsunoh’s research is characterized by its direct clinical applicability, offering evidence-based tools to improve patient counseling and surgical planning in high-stakes prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1